Context Therapeutics Inc. (CNTX) Social Stream
Context Therapeutics Inc (CNTX) Price Targets From Analysts
Use the tables below to see what analysts covering Context Therapeutics Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Over the past 59 days, CNTX's average upside potential has been 295.28%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
CNTX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how Context Therapeutics Inc fares relative to all US stocks, note that its number of analysts covering the stock is higher than 9.42% of that group.
- Context Therapeutics Inc's average analyst price target is higher than 23.53% of all US stocks.
- In the context of stocks in the micro market cap category, Context Therapeutics Inc's variance in analysts' estimates is lower than 29.86% of them.
- CNTX has a greater upside potential (average analyst target price relative to current price) than 212.27% of Healthcare stocks.
In the Pharmaceutical Products industry, CNSP, CLSN, and CLRB are the three stocks most similar to Context Therapeutics Inc regarding the price target and analyst recommendation information presented here.
Is CNTX a Buy, Hold or Sell? See the POWR Ratings now!